Skip to main content

Advertisement

SpringerLink
Log in

Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B

  • CASE REPORT
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P: Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. N Engl J Med 359:1541–1549, 2002

    CAS  Google Scholar 

  2. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ: Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350:876–885, 2004

    Article  CAS  PubMed  Google Scholar 

  3. Hanauer SB: Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther 13 (Suppl 4):16–22, 1999

    Article  CAS  PubMed  Google Scholar 

  4. Oniankitan O, Duvoux C, Challine D, Mallat A, Chevalier X, Pawlotsky JM, Claudepierre P: Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C. J Rheumatol 31:107–109, 2004

    CAS  PubMed  Google Scholar 

  5. Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S: Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686–687, 2003

    CAS  PubMed  Google Scholar 

  6. Michel M, Duvoux C, Hezode C, Cherqui D: Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still’s disease. J Rheumatol 30:1624–1625, 2003

    PubMed  Google Scholar 

  7. Cronstein BN: Molecular therapeutics. Methotrexate and its mechanism of action. Arth Rheum 39:1951–1960, 1996

    CAS  Google Scholar 

  8. Peterson JR, Hsu FC, Simkin PA, Wener MH: Effect of tumor necrosis factor α antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 62:1078–1082, 2003

    Article  CAS  PubMed  Google Scholar 

  9. Campbell S, Ghosh S: Infliximab therapy for Crohn’s disease in the presence of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 13:191–192, 2001

    CAS  PubMed  Google Scholar 

  10. Holtmann MH, Galle PR, Neurath MF: Treatment of patients with Crohn’s disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF. Am J Gastroenterol 98:504–505, 2003

    PubMed  Google Scholar 

  11. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25–36, 1996

    CAS  PubMed  Google Scholar 

  12. Pasquetto V, Wieland S, Uprichard S, Tripodi M, Chisari FV: Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol 76:5646–5653, 2002

    CAS  PubMed  Google Scholar 

  13. Schlaak JF, Tully G, Lohr HF, Gerken G, Meyer zum Buschenfelde KH: HBV-specific immune defect in chronic hepatitis B is correlated with a dysregulation of pro-and anti-inflammatory cytokines. Clin Exp Immunol 115:508–514, 1999

    CAS  PubMed  Google Scholar 

  14. Sandborn WJ, Hanauer SB: Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 5:119–133, 1999

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endoscopy, Hiroshima University Hospital, Higashi–Hiroshima, Japan

    Yoshitaka Ueno MD & Shinji Tanaka MD

  2. Department of Medicine and Molecular Science, Hiroshima University, Hiroshima, Japan

    Masaru Shimamoto MD, Yoshihiro Miyanaka MD, Masanori Ito MD, Yasuhiko Kitadai MD, Masaharu Sumii MD & Kazuaki Chayama MD

  3. Health Service Center, Hiroshima University, Higashi–Hiroshima, Japan

    Toru Hiyama MD & Masaharu Yoshihara MD

Authors
  1. Yoshitaka Ueno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinji Tanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaru Shimamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Miyanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toru Hiyama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masanori Ito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuhiko Kitadai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masaharu Yoshihara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masaharu Sumii MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuaki Chayama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinji Tanaka MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueno, Y., Tanaka, S., Shimamoto, M. et al. Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B. Dig Dis Sci 50, 163–166 (2005). https://doi.org/10.1007/s10620-005-1295-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-1295-8

KEY WORDS

Search

Navigation